 | • レポートコード：MRC309Z7522 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の陽子重粒子線治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の陽子重粒子線治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 陽子重粒子線治療の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 陽子重粒子線治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・陽子線治療、重粒子線治療 用途別セグメント ・医療、研究、その他 主要な市場プレーヤー ・Hitachi、Siemens、Toshiba、SAGA HIMAT、Varian、Ion Beam Applications SA(IBA)、Mevion、Optivus、ProNova 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、陽子重粒子線治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な陽子重粒子線治療メーカーの企業概要、2019年～2022年までの陽子重粒子線治療の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な陽子重粒子線治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別陽子重粒子線治療の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの陽子重粒子線治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での陽子重粒子線治療市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および陽子重粒子線治療の産業チェーンを掲載しています。 ・第14、15章では、陽子重粒子線治療の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 陽子重粒子線治療の概要 - 種類別分析（2018年vs2022年vs2029年）：陽子線治療、重粒子線治療 - 用途別分析（2018年vs2022年vs2029年）：医療、研究、その他 - 世界の陽子重粒子線治療市場規模・予測 - 世界の陽子重粒子線治療生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Hitachi、Siemens、Toshiba、SAGA HIMAT、Varian、Ion Beam Applications SA(IBA)、Mevion、Optivus、ProNova ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：陽子線治療、重粒子線治療 ・用途別分析2018年-2029年：医療、研究、その他 ・陽子重粒子線治療の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・陽子重粒子線治療のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・陽子重粒子線治療のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・陽子重粒子線治療の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・陽子重粒子線治療の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Proton Heavy Ions Radiotherapy market size was valued at USD 1049.5 million in 2022 and is forecast to a readjusted size of USD 1705 million by 2029 with a CAGR of 7.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Proton and heavy ion technology is a kind of radiotherapy, and it is an internationally recognized cutting-edge radiotherapy technology. Protons and heavy ions belong to particle beams. Unlike traditional photon beams, particle beams can form energy Bragg peaks and can concentrate on tumors. While blasting, damage to healthy tissue is reduced.
This report is a detailed and comprehensive analysis for global Proton Heavy Ions Radiotherapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Proton Heavy Ions Radiotherapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Proton Heavy Ions Radiotherapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Proton Heavy Ions Radiotherapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Proton Heavy Ions Radiotherapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Proton Heavy Ions Radiotherapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Proton Heavy Ions Radiotherapy market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hitachi, Siemens, Toshiba, SAGA HIMAT and Varian, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Proton Heavy Ions Radiotherapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Protonic Therapy
Heavy Ion Therapy
Market segment by Application
Medical
Research
Other
Major players covered
Hitachi
Siemens
Toshiba
SAGA HIMAT
Varian
Ion Beam Applications SA(IBA)
Mevion
Optivus
ProNova
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Proton Heavy Ions Radiotherapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Proton Heavy Ions Radiotherapy, with price, sales, revenue and global market share of Proton Heavy Ions Radiotherapy from 2018 to 2023.
Chapter 3, the Proton Heavy Ions Radiotherapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Proton Heavy Ions Radiotherapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Proton Heavy Ions Radiotherapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Proton Heavy Ions Radiotherapy.
Chapter 14 and 15, to describe Proton Heavy Ions Radiotherapy sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Proton Heavy Ions Radiotherapy
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Proton Heavy Ions Radiotherapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Protonic Therapy
1.3.3 Heavy Ion Therapy
1.4 Market Analysis by Application
1.4.1 Overview: Global Proton Heavy Ions Radiotherapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Medical
1.4.3 Research
1.4.4 Other
1.5 Global Proton Heavy Ions Radiotherapy Market Size & Forecast
1.5.1 Global Proton Heavy Ions Radiotherapy Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Proton Heavy Ions Radiotherapy Sales Quantity (2018-2029)
1.5.3 Global Proton Heavy Ions Radiotherapy Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Hitachi
2.1.1 Hitachi Details
2.1.2 Hitachi Major Business
2.1.3 Hitachi Proton Heavy Ions Radiotherapy Product and Services
2.1.4 Hitachi Proton Heavy Ions Radiotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Hitachi Recent Developments/Updates
2.2 Siemens
2.2.1 Siemens Details
2.2.2 Siemens Major Business
2.2.3 Siemens Proton Heavy Ions Radiotherapy Product and Services
2.2.4 Siemens Proton Heavy Ions Radiotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Siemens Recent Developments/Updates
2.3 Toshiba
2.3.1 Toshiba Details
2.3.2 Toshiba Major Business
2.3.3 Toshiba Proton Heavy Ions Radiotherapy Product and Services
2.3.4 Toshiba Proton Heavy Ions Radiotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Toshiba Recent Developments/Updates
2.4 SAGA HIMAT
2.4.1 SAGA HIMAT Details
2.4.2 SAGA HIMAT Major Business
2.4.3 SAGA HIMAT Proton Heavy Ions Radiotherapy Product and Services
2.4.4 SAGA HIMAT Proton Heavy Ions Radiotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 SAGA HIMAT Recent Developments/Updates
2.5 Varian
2.5.1 Varian Details
2.5.2 Varian Major Business
2.5.3 Varian Proton Heavy Ions Radiotherapy Product and Services
2.5.4 Varian Proton Heavy Ions Radiotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Varian Recent Developments/Updates
2.6 Ion Beam Applications SA(IBA)
2.6.1 Ion Beam Applications SA(IBA) Details
2.6.2 Ion Beam Applications SA(IBA) Major Business
2.6.3 Ion Beam Applications SA(IBA) Proton Heavy Ions Radiotherapy Product and Services
2.6.4 Ion Beam Applications SA(IBA) Proton Heavy Ions Radiotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ion Beam Applications SA(IBA) Recent Developments/Updates
2.7 Mevion
2.7.1 Mevion Details
2.7.2 Mevion Major Business
2.7.3 Mevion Proton Heavy Ions Radiotherapy Product and Services
2.7.4 Mevion Proton Heavy Ions Radiotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Mevion Recent Developments/Updates
2.8 Optivus
2.8.1 Optivus Details
2.8.2 Optivus Major Business
2.8.3 Optivus Proton Heavy Ions Radiotherapy Product and Services
2.8.4 Optivus Proton Heavy Ions Radiotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Optivus Recent Developments/Updates
2.9 ProNova
2.9.1 ProNova Details
2.9.2 ProNova Major Business
2.9.3 ProNova Proton Heavy Ions Radiotherapy Product and Services
2.9.4 ProNova Proton Heavy Ions Radiotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 ProNova Recent Developments/Updates
3 Competitive Environment: Proton Heavy Ions Radiotherapy by Manufacturer
3.1 Global Proton Heavy Ions Radiotherapy Sales Quantity by Manufacturer (2018-2023)
3.2 Global Proton Heavy Ions Radiotherapy Revenue by Manufacturer (2018-2023)
3.3 Global Proton Heavy Ions Radiotherapy Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Proton Heavy Ions Radiotherapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Proton Heavy Ions Radiotherapy Manufacturer Market Share in 2022
3.4.2 Top 6 Proton Heavy Ions Radiotherapy Manufacturer Market Share in 2022
3.5 Proton Heavy Ions Radiotherapy Market: Overall Company Footprint Analysis
3.5.1 Proton Heavy Ions Radiotherapy Market: Region Footprint
3.5.2 Proton Heavy Ions Radiotherapy Market: Company Product Type Footprint
3.5.3 Proton Heavy Ions Radiotherapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Proton Heavy Ions Radiotherapy Market Size by Region
4.1.1 Global Proton Heavy Ions Radiotherapy Sales Quantity by Region (2018-2029)
4.1.2 Global Proton Heavy Ions Radiotherapy Consumption Value by Region (2018-2029)
4.1.3 Global Proton Heavy Ions Radiotherapy Average Price by Region (2018-2029)
4.2 North America Proton Heavy Ions Radiotherapy Consumption Value (2018-2029)
4.3 Europe Proton Heavy Ions Radiotherapy Consumption Value (2018-2029)
4.4 Asia-Pacific Proton Heavy Ions Radiotherapy Consumption Value (2018-2029)
4.5 South America Proton Heavy Ions Radiotherapy Consumption Value (2018-2029)
4.6 Middle East and Africa Proton Heavy Ions Radiotherapy Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Proton Heavy Ions Radiotherapy Sales Quantity by Type (2018-2029)
5.2 Global Proton Heavy Ions Radiotherapy Consumption Value by Type (2018-2029)
5.3 Global Proton Heavy Ions Radiotherapy Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Proton Heavy Ions Radiotherapy Sales Quantity by Application (2018-2029)
6.2 Global Proton Heavy Ions Radiotherapy Consumption Value by Application (2018-2029)
6.3 Global Proton Heavy Ions Radiotherapy Average Price by Application (2018-2029)
7 North America
7.1 North America Proton Heavy Ions Radiotherapy Sales Quantity by Type (2018-2029)
7.2 North America Proton Heavy Ions Radiotherapy Sales Quantity by Application (2018-2029)
7.3 North America Proton Heavy Ions Radiotherapy Market Size by Country
7.3.1 North America Proton Heavy Ions Radiotherapy Sales Quantity by Country (2018-2029)
7.3.2 North America Proton Heavy Ions Radiotherapy Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Proton Heavy Ions Radiotherapy Sales Quantity by Type (2018-2029)
8.2 Europe Proton Heavy Ions Radiotherapy Sales Quantity by Application (2018-2029)
8.3 Europe Proton Heavy Ions Radiotherapy Market Size by Country
8.3.1 Europe Proton Heavy Ions Radiotherapy Sales Quantity by Country (2018-2029)
8.3.2 Europe Proton Heavy Ions Radiotherapy Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Proton Heavy Ions Radiotherapy Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Proton Heavy Ions Radiotherapy Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Proton Heavy Ions Radiotherapy Market Size by Region
9.3.1 Asia-Pacific Proton Heavy Ions Radiotherapy Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Proton Heavy Ions Radiotherapy Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Proton Heavy Ions Radiotherapy Sales Quantity by Type (2018-2029)
10.2 South America Proton Heavy Ions Radiotherapy Sales Quantity by Application (2018-2029)
10.3 South America Proton Heavy Ions Radiotherapy Market Size by Country
10.3.1 South America Proton Heavy Ions Radiotherapy Sales Quantity by Country (2018-2029)
10.3.2 South America Proton Heavy Ions Radiotherapy Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Proton Heavy Ions Radiotherapy Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Proton Heavy Ions Radiotherapy Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Proton Heavy Ions Radiotherapy Market Size by Country
11.3.1 Middle East & Africa Proton Heavy Ions Radiotherapy Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Proton Heavy Ions Radiotherapy Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Proton Heavy Ions Radiotherapy Market Drivers
12.2 Proton Heavy Ions Radiotherapy Market Restraints
12.3 Proton Heavy Ions Radiotherapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Proton Heavy Ions Radiotherapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of Proton Heavy Ions Radiotherapy
13.3 Proton Heavy Ions Radiotherapy Production Process
13.4 Proton Heavy Ions Radiotherapy Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Proton Heavy Ions Radiotherapy Typical Distributors
14.3 Proton Heavy Ions Radiotherapy Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer